Your browser doesn't support javascript.
loading
Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Zhu, Fengcai; Huang, Shoujie; Liu, Xiaohui; Chen, Qi; Zhuang, Chunlan; Zhao, Hui; Han, Jinle; Jaen, Anjuli May; Do, Thai Hung; Peter, Jonathan Grant; Dorado, Alexander Gonzalez; Tirador, Louie S; Zabat, Gelza Mae A; Villalobos, Ralph Elvi M; Gueco, Gemalyn Pineda; Botha, Lauren Livia Greta; Iglesias Pertuz, Shirley Patricia; Tan, Jiaxiang; Zhu, Kongxin; Quan, Jiali; Lin, Hongyan; Huang, Yue; Jia, Jizong; Chu, Xiafei; Chen, Junyu; Chen, Yixin; Zhang, Tianying; Su, Yingying; Li, Changgui; Ye, Xiangzhong; Wu, Ting; Zhang, Jun; Xia, Ningshao.
Afiliação
  • Zhu F; Jiangsu Provincial Center for Disease Control and Prevention, Public Health Research Institute of Jiangsu Province, Nanjing, China.
  • Huang S; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, Department of Laboratory Medicine, School of Public Health, Xiamen University, Xiamen, China; National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular
  • Liu X; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, Department of Laboratory Medicine, School of Public Health, Xiamen University, Xiamen, China; National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular
  • Chen Q; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, Department of Laboratory Medicine, School of Public Health, Xiamen University, Xiamen, China; National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular
  • Zhuang C; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, Department of Laboratory Medicine, School of Public Health, Xiamen University, Xiamen, China; National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular
  • Zhao H; National Institute for Food and Drug Control, Beijing, China.
  • Han J; Beijing Wantai Biological Pharmacy Enterprise, Beijing, China.
  • Jaen AM; The Medical City Iloilo, Iloilo City, Philippines.
  • Do TH; Pasteur Institute in Nha Trang, Nha Trang, Viet Nam.
  • Peter JG; University of Cape Town Lung Institute, Mowbray, South Africa.
  • Dorado AG; Bluecare Salud S A S Centro Médico Integral, Bogota, Colombia.
  • Tirador LS; St Paul's Hospital Iloilo, Iloilo City, Philippines.
  • Zabat GMA; Tropical Disease Foundation, Makati City, Philippines.
  • Villalobos REM; UP-Philippine General Hospital, University of the Philippines Manila, Manila, Philippines.
  • Gueco GP; Angeles University Foundation Medical Center, Angeles City, Philippines.
  • Botha LLG; REIMED Reiger Park, Johannesburg, South Africa.
  • Iglesias Pertuz SP; Clínica de la Costa, Barranquilla, Colombia.
  • Tan J; Beijing Wantai Biological Pharmacy Enterprise, Beijing, China.
  • Zhu K; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, Department of Laboratory Medicine, School of Public Health, Xiamen University, Xiamen, China; National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular
  • Quan J; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, Department of Laboratory Medicine, School of Public Health, Xiamen University, Xiamen, China; National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular
  • Lin H; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, Department of Laboratory Medicine, School of Public Health, Xiamen University, Xiamen, China; National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular
  • Huang Y; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, Department of Laboratory Medicine, School of Public Health, Xiamen University, Xiamen, China; National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular
  • Jia J; Beijing Wantai Biological Pharmacy Enterprise, Beijing, China.
  • Chu X; Beijing Wantai Biological Pharmacy Enterprise, Beijing, China.
  • Chen J; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, Department of Laboratory Medicine, School of Public Health, Xiamen University, Xiamen, China; National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular
  • Chen Y; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, Department of Laboratory Medicine, School of Public Health, Xiamen University, Xiamen, China; National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular
  • Zhang T; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, Department of Laboratory Medicine, School of Public Health, Xiamen University, Xiamen, China; National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular
  • Su Y; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, Department of Laboratory Medicine, School of Public Health, Xiamen University, Xiamen, China; National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular
  • Li C; National Institute for Food and Drug Control, Beijing, China.
  • Ye X; Beijing Wantai Biological Pharmacy Enterprise, Beijing, China.
  • Wu T; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, Department of Laboratory Medicine, School of Public Health, Xiamen University, Xiamen, China; National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular
  • Zhang J; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, Department of Laboratory Medicine, School of Public Health, Xiamen University, Xiamen, China; National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular
  • Xia N; State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, Department of Laboratory Medicine, School of Public Health, Xiamen University, Xiamen, China; National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular
Lancet Respir Med ; 11(12): 1075-1088, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37979588
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas Virais / COVID-19 Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas Virais / COVID-19 Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article